Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation

Takehiko Mori, Kaori Hasegawa, Ai Okabe, Natsuki Tsujimura, Yusuke Kawata, Tomoko Yashima, Naoko Kobayashi, Sakiko Kondo, Yoshinobu Aisa, Jun Kato, Kazuyuki Tsunoda, Tetsuo Nagai, Taneaki Nakagawa, Naoyuki Shigematsu, Atsushi Kubo, Yasuo Ikeda, Shinichiro Okamoto

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


High-dose cytarabine is one of the major components of the conditioning regimen for hematopoietic stem cell transplantation (HSCT), and frequently causes severe oral mucositis. We have recently demonstrated that cytarabine is excreted into the saliva in patients receiving high-dose cytarabine, and proposed that it might locally and directly contribute to the development of oral mucositis. Therefore, this study was performed to assess whether removing the excreted cytarabine in the saliva by intensive mouth rinse during high-dose cytarabine infusion could reduce the incidence of oral mucositis. Fifteen patients with hematologic malignancies undergoing allogeneic HSCT who received total body irradiation (12 Gy) and high-dose cytarabine at a dose of 3 g/m 2 every 12 h for 4 days as a conditioning were evaluated. Patients were instructed to rinse their mouths using ice-cold water every 10 min, starting simultaneously with the 2-h cytarabine infusion and continuing up to 1 h after completion of each infusion. Oral mucositis was graded on a daily basis according to the National Cancer Institute, Common Toxicity Criteria. Thirty-five patients who previously underwent the same conditioning without mouth rinse served as controls. The incidence of Grades 2-3 and Grade 3 oral mucositis was significantly reduced in patients who performed mouth rinse as compared with the controls (40 vs. 80%, P = 0.009; 0 vs. 25. 7%, P = 0.02). In conclusion, mouth rinse during and shortly after high-dose cytarabine infusion could be an effective and inexpensive measure in reducing the incidence of moderate to severe oral mucositis caused by high-dose cytarabine. This finding strongly suggests the role of cytarabine excretion in the saliva in the development of cytarabine-associated oral mucositis.

Original languageEnglish
Pages (from-to)583-587
Number of pages5
JournalInternational journal of hematology
Issue number5
Publication statusPublished - 2009 Dec


  • Hematopoietic stem cell transplantation
  • High-dose cytarabine
  • Mouth rinse
  • Oral mucositis

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this